Results 191 to 200 of about 62,277 (245)

Relationship Between Clozapine-Induced Inflammation and Eosinophilia: A Retrospective Cohort Study. [PDF]

Schizophr Bull
Kikuchi Y, Otsuka Y, Ito F, Yada Y, Tanifuji H, Komatsu H, Tomita H.   +6 more
europepmc   +1 more source

Management of Parkinson's disease psychosis-a European perspective. [PDF]

Lancet Reg Health Eur
Pirker W, Ferreira JJ, Rascol O, Poewe W.   +3 more
europepmc   +1 more source

Trends in use of antipsychotics in Germany 2014-2024: a nationwide population-based study. [PDF]

BMC Psychiatry
Espinosa Daudí A, Kieble M, Schulz M.
europepmc   +1 more source

Question: What Are the Management Options for Treatment-Resistant Bipolar Disorder With Recurrent Mood Switches Despite Being on Clozapine, Lithium, Lamotrigine, and Ketamine? [PDF]

J Clin Psychopharmacol
Singh B.
europepmc   +1 more source

Quantifying improvement of psychotic symptoms in clozapine-treated schizophrenia: clinical note analysis with large language models. [PDF]

Sci Rep
Matsumura M, Nishida K, Toyoda K, Kadoyama K, Yano R, Kanazawa T, Nakamura T, Morishima Y.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Clozapine

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1991
Clozapine is a neuroleptic agent whose structure consists of a dibenzodiazepine derivative with a piperazinyl side chain. It has been classified as an atypical neuroleptic drug due to its unique neuropharmacologic profile. Clozapine has a weak binding affinity for dopamine D‐1 and D‐2 receptors by its slightly greater preference ...
openaire   +2 more sources